本页面由Tiger Trade Technology Pte. Ltd.提供服务

Cardiol Therapeutics Inc

1.05
-0.0050-0.48%
成交量:11.54万
成交额:12.14万
市值:1.20亿
市盈率:-3.74
高:1.07
开:1.05
低:1.04
收:1.05
52周最高:1.71
52周最低:0.8800
股本:1.15亿
流通股本:9,988.92万
量比:1.26
换手率:0.12%
股息:- -
股息率:- -
每股收益(TTM):-0.2791
每股收益(LYR):-0.2835
净资产收益率:-173.96%
总资产收益率:-78.25%
市净率:7.07
市盈率(LYR):-3.69

数据加载中...

2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/31

年度报告

Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2025/04/01

年度报告

Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2024/11/06

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/04/01

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/03/29

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/04/20

[修订]年度报告

40-F/A [Amend] - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2022/03/24

年度报告

40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2022/02/07

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/18

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/01/18

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/11/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/08/19

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans